Novel Agents to Manage Dyslipidemias and Impact Atherosclerosis

Publisher： Bentham Science Publishers

E-ISSN： 2212-4063|6|3|209-217

ISSN： 1871-529X

Source： Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders), Vol.6, Iss.3, 2006-09, pp. : 209-217

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel Immunosuppressive Agents in Tolerance Induction

By  

Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 2, Iss. 2, 2002-12 ,pp. : 97-103

Bentham Science Publishers

Access to resources Recommend Favorite

Hsp90 inhibitors as novel cancer chemotherapeutic agents

By Neckers L.  

Trends in Molecular Medicine, Vol. 8, Iss. 4, 2002-04 ,pp. : 55-61

Elsevier

Access to resources Recommend Favorite

Agents for the Inhibition of Cholesteryl Ester Transfer Protein (CETP) and Prospects for the Future Treatment of Atherosclerosis

By  

Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents, Vol. 5, Iss. 4, 2005-08 ,pp. : 339-360

Bentham Science Publishers

Access to resources Recommend Favorite

The gene expression of TNF-α and ICAM-1 as novel markers for atherosclerosis in Egyptian hemodialysis patients

By El-Sayed Laila H.  

International Journal of Immunological Studies, Vol. 1, Iss. 1, 2009-02 ,pp. : 94-105

Inderscience Publishers

Access to resources Recommend Favorite

Non-invasive Atherosclerosis Imaging: Use to Assess Response to Novel or Combination Lipid Therapies

By  

Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, Iss. 6, 2005-12 ,pp. : 557-564

Bentham Science Publishers

Access to resources Recommend Favorite